Depression in multiple sclerosis: a review

RJ Siegert, DA Abernethy - Journal of Neurology, Neurosurgery & …, 2005 - jnnp.bmj.com
Several studies have reported high rates of depression in multiple sclerosis (MS) with a
lifetime prevalence of∼ 50% and an annual prevalence of 20% not uncommon. Concern …

Cognitive dysfunctions and assessments in multiple sclerosis

C Oreja-Guevara, T Ayuso Blanco… - Frontiers in …, 2019 - frontiersin.org
Cognitive impairment has been reported at all phases and all subtypes of multiple sclerosis.
It remains a major cause of neurological disability in young and middle-aged adults suffering …

Quality of life in multiple sclerosis: the impact of depression, fatigue and disability

MP Amato, G Ponziani, F Rossi… - Multiple Sclerosis …, 2001 - journals.sagepub.com
This study deals with the assessment of quality of life and its main clinical and
demographical determinants in a clinical series of 103 patients with multiple sclerosis …

Autoimmune diseases, bipolar disorder, and non‐affective psychosis

WW Eaton, MG Pedersen, PR Nielsen… - Bipolar …, 2010 - Wiley Online Library
Eaton WW, Pedersen MG, Nielsen PR, Mortensen PB. Autoimmune diseases, bipolar
disorder, and non‐affective psychosis. Bipolar Disord 2010: 12: 638–646.© 2010 The …

Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the …

SL Minden, A Feinstein, RC Kalb, D Miller, DC Mohr… - Neurology, 2014 - AAN Enterprises
Objective: To make evidence-based recommendations for screening, diagnosing, and
treating psychiatric disorders in individuals with multiple sclerosis (MS). Methods: We …

Structural brain abnormalities in multiple sclerosis patients with major depression

A Feinstein, P Roy, N Lobaugh, K Feinstein… - Neurology, 2004 - AAN Enterprises
Objective: To assess the association between major depression and structural brain
abnormalities in patients with multiple sclerosis (MS). Methods: Two groups of patients with …

The Goldman Consensus statement on depression in multiple sclerosis

Goldman Consensus Group - Multiple Sclerosis Journal, 2005 - journals.sagepub.com
Background. In January 2002 the New York City Chapter of the National Multiple Sclerosis
Society convened a panel of experts to review the issue of depressive affective disorders …

Cytokines as biomarkers in depressive disorder: current standing and prospects

N Lichtblau, FM Schmidt, R Schumann… - International review of …, 2013 - Taylor & Francis
The frequently observed co-occurrence of depressive disorders and inflammatory diseases
suggests a close connection between the nervous and the immune systems. Increased pro …

Psychiatric issues in multiple sclerosis

LA Chwastiak, DM Ehde - Psychiatric Clinics of North America, 2007 - Elsevier
Multiple sclerosis (MS) is the most common chronic disabling disease of the central nervous
system in young adults. Early onset and long duration of disease result in tremendous …

The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour

T Paparrigopoulos, P Ferentinos… - International review of …, 2010 - Taylor & Francis
Neuropsychiatric symptoms are common in multiple sclerosis (MS). They include two broad
categories of disturbances: abnormalities in cognition, and abnormalities of mood, affect and …